XML 17 R47.htm IDEA: XBRL DOCUMENT v3.2.0.727
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
ASSETS      
Marketable securities $ 74,637   $ 53,074
Liabilities      
Operational Gain (losses) recognized in earnings (5,254) $ (17,639)  
Financial Gain (losses) recognized in earnings (259) (157)  
Total (5,513) (17,796)  
Cash and Cash Equivalents [Member]      
ASSETS      
Cash and cash equivalent 38,536   39,760
Liabilities      
Operational Gain (losses) recognized in earnings 0 0  
Financial Gain (losses) recognized in earnings 0 0  
Total 0 0  
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]      
ASSETS      
Cash and cash equivalent 38,536    
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]      
ASSETS      
Cash and cash equivalent 0    
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]      
ASSETS      
Cash and cash equivalent 0    
Marketable Securities [Member]      
ASSETS      
Marketable securities 74,637   53,074
Liabilities      
Operational Gain (losses) recognized in earnings 0 0  
Financial Gain (losses) recognized in earnings 531 0  
Total 531 0  
Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
ASSETS      
Marketable securities 74,637    
Marketable Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
ASSETS      
Marketable securities 0    
Marketable Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
ASSETS      
Marketable securities 0    
Acquisition Liability Contingent Consideration [Member]      
Liabilities      
Acquisition liability contingent consideration [1] 72,169   70,112
Operational Gain (losses) recognized in earnings [1] (2,380) (849)  
Financial Gain (losses) recognized in earnings [1] 0 0  
Total [1] (2,380) (849)  
Acquisition Liability Contingent Consideration [Member] | Fair Value, Inputs, Level 1 [Member]      
Liabilities      
Acquisition liability contingent consideration [1] 0    
Acquisition Liability Contingent Consideration [Member] | Fair Value, Inputs, Level 2 [Member]      
Liabilities      
Acquisition liability contingent consideration [1] 0    
Acquisition Liability Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member]      
Liabilities      
Acquisition liability contingent consideration [1] 72,169    
Acquisition Liability Note [Member]      
Liabilities      
Acquisition liability contingent consideration [2] 0   0
Operational Gain (losses) recognized in earnings [2] 0 (3,013)  
Total [2] 0 (3,013)  
Acquisition Liability Note [Member] | Fair Value, Inputs, Level 1 [Member]      
Liabilities      
Acquisition liability contingent consideration [2] 0    
Acquisition Liability Note [Member] | Fair Value, Inputs, Level 2 [Member]      
Liabilities      
Acquisition liability contingent consideration [2] 0    
Acquisition Liability Note [Member] | Fair Value, Inputs, Level 3 [Member]      
Liabilities      
Acquisition liability contingent consideration [2] 0    
Acquisition Liability Warrant Consideration [Member]      
Liabilities      
Acquisition liability contingent consideration [3] 37,417   34,542
Operational Gain (losses) recognized in earnings [3] (2,875) (13,777)  
Financial Gain (losses) recognized in earnings [3] 0 0  
Total [3] (2,875) (13,777)  
Acquisition Liability Warrant Consideration [Member] | Fair Value, Inputs, Level 1 [Member]      
Liabilities      
Acquisition liability contingent consideration [3] 0    
Acquisition Liability Warrant Consideration [Member] | Fair Value, Inputs, Level 2 [Member]      
Liabilities      
Acquisition liability contingent consideration [3] 0    
Acquisition Liability Warrant Consideration [Member] | Fair Value, Inputs, Level 3 [Member]      
Liabilities      
Acquisition liability contingent consideration [3] 37,417    
Deerfield Royalty Agreement [Member]      
Liabilities      
Acquisition liability contingent consideration [4] 6,973   6,837
Operational Gain (losses) recognized in earnings [4]   0  
Financial Gain (losses) recognized in earnings [4] (176) (105)  
Total [4] (176) (105)  
Deerfield Royalty Agreement [Member] | Fair Value, Inputs, Level 3 [Member]      
Liabilities      
Acquisition liability contingent consideration [4] 6,973    
Broadfin Royalty Agreement [Member]      
Liabilities      
Acquisition liability contingent consideration [4] 3,323   $ 3,259
Operational Gain (losses) recognized in earnings [4]   0  
Financial Gain (losses) recognized in earnings [4] (83) (52)  
Total [4] (83) $ (52)  
Broadfin Royalty Agreement [Member] | Fair Value, Inputs, Level 3 [Member]      
Liabilities      
Acquisition liability contingent consideration [4] $ 3,323    
[1] Acquisition liability contingent consideration: the fair value is estimated using a discounted cash flow model based on probability adjusted projected annual gross profit of each of the products which formed the project portfolio at the time of acquisition of Éclat Pharmaceuticals (Note 10 Long Term Debt). The fair value of the contingent consideration will change over time in accordance with the changes in market conditions and thus business plan projections as the relate to market size, market share, product pricing, competitive landscape, gross profit margins expected for each of the products.
[2] Acquisition liability Note: the Company uses a probability-weighted discounted cash flow model (see note 10 Long Term Debt). The note was repaid on March 24, 2014.
[3] Acquisition liability warrant consideration: the Company uses a Black-Scholes option pricing model. The fair value of the warrant consideration will change over time depending on the volatility and share price at balance sheet date (see note 10 Long Term Debt).
[4] Broadfin and Deerfield Royalty Agreement: the fair value is estimated using a discounted cash flow model based on probability adjusted projected annual net sales of each of the products which may be approved and sold by Éclat Pharmaceuticals (Note 10 Long Term Debt). The discount rate is 20%.